The study demonstrated that early tirzepatide use in metformin-treated T2DM achieved greater reductions in HbA1c, weight, & waist circumference, with more patients reaching normoglycemia at 2 yrs vs intensified conventional care.
This presentation summarizes the key findings based on pulmonologists’ perspectives from a survey conducted to understand clinicians perspectives and practice patterns in both the diagnosis and treatment of group 1 and group 3 PH, which can further help optimize the management of PH patients.